Lunit vs Molecular Health
Lunit vs Molecular Health, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Lunit is on 61/100 and Molecular Health on 54/100.
Where each one leads
Lunit
- our overall score: 61/100 against 54/100
- agent readiness: 37/100 against 21/100
- domain rating: 63/100 against 34/100
- headcount: 370 against 75
- funding raised: $1.1B against $26.8M
Molecular Health
- LinkedIn following: 11,421 against 829
At a glance
| Measure | Lunit | Molecular Health |
|---|---|---|
| What it is | Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics. | Data-driven software solutions for precision medicine and pharmaceutical development. |
| Category | HealthTech, MedTech, AI-Driven Protein Design, Biotech | HealthTech, Biotech, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2013 | 2004 |
| Headquarters | Seoul, South Korea | Heidelberg, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | Lunit | Molecular Health |
|---|---|---|
| Employees | 370 | 75 |
| Headcount growthLast 12 months | +14.1% | Not published |
| Total funding | $1.1B | $26.8M |
| Latest round | Rights Offering | PE |
| LinkedIn followers | 829 | 11,421 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Lunit | Molecular Health |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 54/100 |
| Traction | Not published | 56/100 |
| Team | 100/100 | 70/100 |
| Search visibility | 53/100 | 23/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Lunit | Molecular Health |
|---|---|---|
| Hosting | AWS | Self Managed |
| CDN | CloudFront | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Segment |
| Support stack | Not detected | HubSpot |
Lunit vs Molecular Health: common questions
Which is better, Lunit or Molecular Health?
On our 0-100 score Lunit rates higher (61/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Lunit and Molecular Health compare on the numbers?
Lunit leads on our overall score (61/100 against 54/100), agent readiness (37/100 against 21/100), domain rating (63/100 against 34/100), headcount (370 against 75), funding raised ($1.1B against $26.8M). Molecular Health leads on LinkedIn following (11,421 against 829).
Read the full Lunit review and pricing or the Molecular Health review and pricing. You can also browse other Lunit alternatives we track.